0001954759-26-000004.txt : 20260928 0001954759-26-000004.hdr.sgml : 20260928 20260928083653 ACCESSION NUMBER: 0001954759-26-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260928 DATE AS OF CHANGE: 20260928 EFFECTIVENESS DATE: 20260928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evia Bio, Inc. CENTRAL INDEX KEY: 0001954759 ORGANIZATION NAME: EIN: 851985200 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598967 FILM NUMBER: 261412052 BUSINESS ADDRESS: STREET 1: MCGUIRE TRANSLATIONAL RESEARCH FACILITY STREET 2: 2001 6TH ST SE ROOM 2-434 CITY: MINNEAPOLIS STATE: MN ZIP: 55455 BUSINESS PHONE: (888) 594-0411 MAIL ADDRESS: STREET 1: MCGUIRE TRANSLATIONAL RESEARCH FACILITY STREET 2: 2001 6TH ST SE ROOM 2-434 CITY: MINNEAPOLIS STATE: MN ZIP: 55455 D 1 primary_doc.xml X0708 D LIVE 0001954759 Evia Bio, Inc. 2001 6th Street SE, Room 2-434 Bench 33 Minneapolis MN MINNESOTA 55455 414 852-0037 DELAWARE BlueCube Bio, Inc. None Corporation true Jeffrey Allen 2001 6th Street SE, Room 2-434 Bench 33 Minneapolis MN MINNESOTA 55455 Executive Officer Director Marc Centrella 2001 6th Street SE, Room 2-434 Bench 33 Minneapolis MN MINNESOTA 55455 Director Scott Fisher 2001 6th Street SE, Room 2-434 Bench 33 Minneapolis MN MINNESOTA 55455 Director Allison Hubel 2001 6th Street SE, Room 2-434 Bench 33 Minneapolis MN MINNESOTA 55455 Director Troy Wichterman 2001 6th Street SE, Room 2-434 Bench 33 Minneapolis MN MINNESOTA 55455 Director Biotechnology Decline to Disclose 06b false 2026-09-14 false true false 0 5453532 5453532 0 In addition to the shares sold for cash in the offering $3,453,532.33 of Convertible Promissory Notes converted into shares of the Issuer's Preferred Stock. false 19 0 0 95192 Accrued consulting fees. false Evia Bio, Inc. Jeffrey Allen Jeffrey Allen CEO 2026-09-28